NCT02712905 2025-11-04An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated116 enrolled 36 charts
NCT00617409 2019-11-08To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic AcidH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed69 enrolled 10 charts